Search - tctmd.com

Displaying 1 - 20 of 34

Sort: Relevancy | Date

News Daily News

Certain Coronary Cases, Like STEMI, Tip Total Radiation Exposure Higher

L.A. McKeown

January 27, 2026

News Daily News

Some Ups, Some Downs in Proposed CMS Reimbursement for 2026, Cardiologists Say

L.A. McKeown

July 22, 2025

News Daily News

Pregnancy Health, Mortality Link Especially Pronounced in Black Women

Yael L. Maxwell

March 17, 2023

News Daily News

Sodium Restriction No Help, No Harm in HF, Meta-analysis Confirms

Shelley Wood

November 23, 2022

News Daily News

More Endpoints, More Problems: FDA Offers Advice for Multi-endpoint Trials

Michael O'Riordan

October 28, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2022

Todd Neale

August 01, 2022

News Daily News

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

Caitlin E. Cox

July 08, 2022

News Daily News

Omega-3 Fatty Acids Linked to BP Reductions, Meta-analysis Hints

L.A. McKeown

June 06, 2022

News Conference News AHA 2021

No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials

Todd Neale

November 15, 2021

News Featured Fellow

Chandana Shekar, MD

Yael L. Maxwell

January 28, 2021

News Opinion Editor's Corner

The Biggest News of 2020: TCTMD’s Top 10

Shelley Wood

December 28, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2020

Shelley Wood

November 30, 2020

News Conference News AHA 2020

OMEMI: Omega-3 Fatty Acids No Help in Elderly MI Patients

Todd Neale

November 15, 2020

News Daily News

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Michael O'Riordan

August 06, 2020

News Daily News

SMASH: Population-Based Sodium Reduction Sees Success in China

L.A. McKeown

April 28, 2020

News Opinion Editor's Corner

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

Shelley Wood

March 16, 2020

News Conference News

ACC, EHRA Cancel 2020 Meetings Over COVID-19

Michael O'Riordan

March 09, 2020

News Daily News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Michael O'Riordan

January 03, 2020

News Daily News

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Michael O'Riordan

November 14, 2019

News Conference News ESC 2019

Updated EAS/ESC Dyslipidemia Guidelines Lower LDL Targets, Broaden Risk Categories

Yael L. Maxwell

September 06, 2019

Advertisement

Certain Coronary Cases, Like STEMI, Tip Total Radiation Exposure Higher

Some Ups, Some Downs in Proposed CMS Reimbursement for 2026, Cardiologists Say

Pregnancy Health, Mortality Link Especially Pronounced in Black Women

Sodium Restriction No Help, No Harm in HF, Meta-analysis Confirms

More Endpoints, More Problems: FDA Offers Advice for Multi-endpoint Trials

TCTMD’s Top 10 Most Popular Stories for July 2022

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

Omega-3 Fatty Acids Linked to BP Reductions, Meta-analysis Hints

No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials

Chandana Shekar, MD

The Biggest News of 2020: TCTMD’s Top 10

TCTMD’s Top 10 Most Popular Stories for November 2020

OMEMI: Omega-3 Fatty Acids No Help in Elderly MI Patients

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

SMASH: Population-Based Sodium Reduction Sees Success in China

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

ACC, EHRA Cancel 2020 Meetings Over COVID-19

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Updated EAS/ESC Dyslipidemia Guidelines Lower LDL Targets, Broaden Risk Categories

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content